Clinical Trials

Phase 4 Active not recruiting

Metastatic Castration-resistant Prostate Cancer

NCT07221838 2026-04-09

OCTAGON

Phase 4 Recruiting

75 enrolled

Adrenal Insufficiency, Myasthenia Gravis

NCT03016741 2026-02-24

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Phase 4 Not yet recruiting

Dementia, Prostatic Neoplasms, Cognitive Dysfunction, Prostatic Neoplasms, Castration-Resistant

NCT07426484 2026-02-23

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

80 enrolled

DermatologicLymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Waldenstrom Macroglobulinemia, Skin Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell

NCT02858804 2026-02-11

BDH-MCL01

Phase 4 Active not recruiting

55 enrolled

Lymphoid

Lymphoma, Mantle-Cell

NCT03829371 2025-12-03

STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA

450 enrolled

Plasma cell

Multiple Myeloma

NCT06723548 2024-12-09

Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis

Phase 4 Not yet recruiting

30 enrolled

Autoimmune Diseases, Myasthenia Gravis

NCT01995513 2023-09-18

PLATO

509 enrolled 18 charts

Prostatic Neoplasms

NCT04036721 2023-02-23

PROS-CONS

Phase 4 Suspended

85 enrolled

Thoracic

Lung Neoplasms, Pneumonia, Lung Diseases, Interstitial

NCT02752815 2022-12-05

Reduced Chemotherapy in Low Risk DLBCL

290 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02485691 2022-05-27

CARD

255 enrolled 21 charts

Prostate Cancer Metastatic

NCT00853008 2020-04-07

LAL-AR/2003

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02773550 2020-01-18

Velcadito

Phase 4 Terminated

24 enrolled

Plasma cell

Multiple Myeloma

NCT01746992 2017-11-14

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma

200 enrolled

DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Immunoblastic Lymphadenopathy, Enteropathy-Associated T-Cell Lymphoma

NCT02878161 2016-08-25

Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"

240 enrolled

Arthritis, Rheumatoid

NCT01649635 2016-07-06

PROSPECTA

45 enrolled

Prostatic Neoplasms

NCT02074137 2016-06-02

Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer

10 enrolled

Prostate Cancer Metastatic

NCT00526175 2016-01-20

LAL-BR/2001: Study Treatment to Low Risk ALL

150 enrolled

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02190994 2014-07-15

Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions

CNSEndocrine

Craniopharyngioma, Pituitary Neoplasms

NCT01358253 2014-05-20

Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00526305 2010-01-05

LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00797810 2009-09-15

Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults

25 enrolled

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00494897 2009-05-19

PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia

374 enrolled